Oregon State University researchers have developed a new weapon in the battle against antibiotic-resistant germs – a molecule that neutralizes the bugs’ ability to destroy the antibiotic.
Scientists at OSU were part of an international collaboration that demonstrated the molecule’s ability to inhibit expression of an enzyme that makes bacteria resistant to a wide range of penicillins.
The molecule is a PPMO, short for peptide-conjugated phosphorodiamidate morpholino oligomer. The enzyme it combats is known as New Delhi metallo-beta-lactamase, or NDM-1, and it’s accompanied by additional genes that encode resistance to most if not all antibiotics.
“We’re targeting a resistance mechanism that’s shared by a whole bunch of pathogens,” said Bruce Geller, professor of microbiology in OSU’s College of Science and College of Agricultural Sciences, who’s been researching molecular medicine for more than a decade. “It’s the same gene in different types of bacteria, so you only have to have one PPMO that’s effective for all of them, which is different than other PPMOs that are genus specific.”
The Oregon State study showed that in vitro the new PPMO restored the ability of an antibiotic — in this case meropenem, an ultra-broad-spectrum drug of the carbapenem class — to fight three different genera of bacteria that express NDM-1. The research also demonstrated that a combination of the PPMO and meropenem was effective in treating mice infected with a pathogenic strain of E. coli that is NDM-1 positive.
Results of the study, supported by a grant from the National Institutes of Health, were recently published in the Journal of Antimicrobial Chemotherapy.
Geller says the PPMO will likely be ready for testing in humans in about three years.
“We’ve lost the ability to use many of our mainstream antibiotics,” Geller said. “Everything’s resistant to them now. That’s left us to try to develop new drugs to stay one step ahead of the bacteria, but the more we look the more we don’t find anything new. So that’s left us with making modifications to existing antibiotics, but as soon as you make a chemical change, the bugs mutate and now they’re resistant to the new, chemically modified antibiotic.”
That progression, Geller explains, made the carbapenems, the most advanced penicillin-type antibiotic, the last line of defense against bacterial infection.
“The significance of NDM-1 is that it is destroys carbapenems, so doctors have had to pull out an antibiotic, colistin, that hadn’t been used in decades because it’s toxic to the kidneys,” Geller said. “That is literally the last antibiotic that can be used on an NDM-1-expressing organism, and we now have bacteria that are completely resistant to all known antibiotics. But a PPMO can restore susceptibility to antibiotics that have already been approved, so we can get a PPMO approved and then go back and use these antibiotics that had become useless.”
Receive an email update when we add a new ANTIBIOTIC RESISTANCE article.
The Latest on: Antibiotic resistance
via Google News
The Latest on: Antibiotic resistance
- Expert stresses need to check antibiotics abuseon December 11, 2019 at 10:11 am
Fr Cherian J.Kottayil, MACFAST Principal, inaugurated the club. Philip Mathew, physician and ReAct Asia Pacific consultant, delivered the keynote address on antibiotic resistance on the occasion. Dr.
- Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sinkon December 11, 2019 at 8:30 am
In a prepared statement, Iterum CEO Corey Fishman characterized the result as “narrowly missing the primary endpoint.” He added that the data show potential for the drug to address growing antibiotic ...
- People in the U.S. Are Buying Fish Antibiotics Online and Taking Them Themselveson December 11, 2019 at 7:30 am
and contribute to the development of antibiotic resistance." Products intended for animals also aren't FDA-approved, he said, "and while the appearance is identical in our initial assessment, this ...
- Diversity of P1 phage-like elements in multidrug resistant Escherichia colion December 11, 2019 at 2:31 am
The spread of multidrug resistance via mobile genetic elements is a major clinical and veterinary concern. Pathogenic Escherichia coli harbour antibiotic resistance and virulence genes mainly on ...
- Veterinary Antibiotics Market Global Demand, Growth, Opportunities, Top Key Players and Forecast to 2027on December 11, 2019 at 1:33 am
Growing concerns over antibiotic resistance in human beings coupled with rising demand for milk, eggs and meat is influencing the veterinary antibiotic market across the globe. Rising prevalence of ...
- Scientists discover a novel method to combat antibiotic-resistant bacteriaon December 10, 2019 at 11:02 am
fears that we may soon slip back into a situation similar to the pre-antibiotic era. The death toll caused by antimicrobial resistance is estimated to rise to 10 million deaths annually by 2050 with ...
- Antibiotic Resistance Mechanism Shows Achilles’ Heelon December 10, 2019 at 5:26 am
The finding could lead to the development of new strategies against vancomycin-resistant enterococci (VRE), which causes thousands of deaths in the United States alone. Antibiotic resistance ...
- Researchers identify 'Achilles' heel' of drug-resistant superbugon December 9, 2019 at 12:04 pm
However, the secret is out now that researchers at The University of Texas Health Science Center at Houston (UTHealth) have identified the protein that acts as a defense mechanism for ...
- As antibiotic resistance increases, look to bacteriophage to fight infectionson December 6, 2019 at 2:30 pm
Perhaps instead of thwarting nature, we should enlist it in our fight against the organisms that can cause us harm. Antibiotics are not the only things that kill bacteria: Viruses that attack bacteria ...
via Bing News